Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03919084 · ClinicalTrials.gov registry record · NA
THRIVE+ Pharmacy Liaison-Patient Navigation Intervention
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 364
- Enrollment target
NCT03919084 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 364 participants.
The verdict
NCT03919084, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 364 participants
- Enrollment target
Study Summary
This is a pragmatic comparative effectiveness trial (n=364) to compare two screening and referral program models to address health-related social needs (HRSN) among the intermediate risk population of Boston Accountable Care Organization (BACO), a Medicaid ACO. The first study arm is THRIVE-Basic, the low-touch usual care model already implemented in all primary care clinics at Boston Medical Center (BMC) where patients are screened for HRSN and receive a printed paper resource referral guide. The second study arm is THRIVE+, which enhances the THRIVE-Basic model by engaging a pharmacy liaison-patient navigator to provide targeted navigation services and motivational interviewing to ensure connection to hospital- and community-based resources. The patient navigators will also interface directly with a partner community organization, Action for Boston Community Development (ABCD), to further help connect patients receiving THRIVE+ to community resources for HRSN. All patients in our study will receive pharmacy services via an existing Pharmacy Care Program. Patients in study arm 1 will be connected to a pharmacy liaison, which is standard clinical practice for intermediate risk ACO members in the BMC General Internal Medicine clinics. Patients in study arm 2 will receive systematic screening for and addressing of HRSN (THRIVE+) via a pharmacy liaison-patient navigator (a pharmacy technician trained as a patient navigator to deploy both pharmacy services and the THRIVE+ intervention), thereby avoiding duplication of services and multiple touches. Assignment to the study arms will be linked to existing Pharmacy Care Program enrollment activities and will be based on medical record number. The investigators' rationale for the study is that if patients' HRSN are addressed, patients will be better positioned to manage chronic conditions, adhere to preventive care plans, and less likely to use the emergency department (a conduit to inpatient care) for ambulatory care-sensi
Interventions
- OTHER Motivational Interviewing
- OTHER THRIVE screening and referral
- OTHER Pharmacy Care Program services
- OTHER Patient Navigation Services
- OTHER Linkage to Community Partner Organization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 364 participants |
| Start Date | 2019-05-28 |
| Est. Completion | 2021-03-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03919084
The ClinicalTrials.gov registry entry for NCT03919084 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 364 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Motivational Interviewing is the first listed.
NCT03919084 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03919084 about?
NCT03919084 is a clinical study titled "THRIVE+ Pharmacy Liaison-Patient Navigation Intervention". This is a pragmatic comparative effectiveness trial (n=364) to compare two screening and referral program models to address health-related social needs (HRSN) among the intermediate risk population of Boston Accountable Care Organization (BACO), a Medicaid ACO. The first study arm is THRIVE-Basic, t...
What is the current status of trial NCT03919084?
This trial is currently completed. It is a NA study. The enrollment target is 364 participants. The study started on 2019-05-28. Estimated completion is 2021-03-05.
What interventions are being tested in trial NCT03919084?
The interventions under investigation include: Motivational Interviewing (OTHER), THRIVE screening and referral (OTHER), Pharmacy Care Program services (OTHER), Patient Navigation Services (OTHER), Linkage to Community Partner Organization (OTHER).
Who is sponsoring clinical trial NCT03919084?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.